HomeQuestion

Which patients with resectable/borderline resectable pancreas adenocarcinoma are you offering perioperative PAXG Abraxane/cisplatin/capecitabine/gemcitabine?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?

Do you incorporate the ALASCCA trial into your clinical practice and perform NGS on all early stage colon cancer patients to determine if adjuvant aspirin would be beneficial?

Are you comfortable using durvalumab + tremelimumab in advanced HCC with portal vein thrombus, when these patients were not included in the HIMALAYA trial?

What is the preferred second-line therapy for HER2-positive patients with esophageal squamous cell carcinoma who have progressed on first line Trastuzumab and Immunotherapy?

How are you interpreting the early RASolute 302 trial findings (daraxonrasib) in metastatic PDAC?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.